Augenheilkunde Up2date is a pivotal journal in the field of ophthalmology, published by GEORG THIEME VERLAG KG, a renowned publisher known for its commitment to advancing medical knowledge. With its ISSN 1616-9719 and E-ISSN 1616-9735, this journal serves as a vital resource for researchers, professionals, and students interested in the latest developments and nuanced discussions in eye health. Although not available as open access, its curated content offers significant insights into contemporary research, clinical practices, and emerging trends in ophthalmology, thus promoting the continuous professional development of its readers. There is an emphasis on providing comprehensive reviews that encapsulate the pertinent advancements in the field, making it an essential publication for those aiming to enhance their expertise in eye care and vision science.

MOLECULAR VISION is a premier open-access journal that has been advancing the field of ophthalmology since its inception in 1995. Published by MOLECULAR VISION, this journal boasts a strong reputation, currently ranking in the second quartile (Q2) of its category, with a Scopus ranking of 35 out of 137, placing it in the 74th percentile among peer publications. Dedicated to disseminating groundbreaking research and innovative findings in the study of vision and ocular health, MOLECULAR VISION serves as a vital resource for researchers, healthcare professionals, and students engaged in this dynamic field. The journal welcomes contributions spanning fundamental and clinical research, offering a platform for crucial knowledge exchange that is essential for advancing ocular health and function. With its commitment to open access, readers around the globe can freely access and build upon the wealth of information disseminated through its pages, ensuring that the latest developments in ophthalmology are available to all.

Clinical and Experimental Optometry, published by Taylor & Francis Ltd, is a distinguished journal dedicated to advancing the field of optometry and ophthalmology. With an impressive scope covering both clinical practices and experimental research, this journal serves as a vital resource for researchers, healthcare professionals, and students alike. Recognized in the Q2 category for Ophthalmology and Q1 category for Optometry in 2023, it underscores its significance in fostering innovative research and clinical knowledge. The journal has been in publication since 1986 and continues to accept contributions up until 2024, reflecting its ongoing commitment to disseminating high-quality scholarly work. With a Scopus ranking of 40 in Ophthalmology and 5 in Health Professions - Optometry, it is positioned among the leading journals in the field. Although not an open-access journal, it remains integral for anyone invested in the latest trends and findings in vision science, making it an essential part of the academic landscape in the UK and beyond.

Contact Lens & Anterior Eye is a premier journal dedicated to advancing the field of optometry, ophthalmology, and overall visual health. Published by Elsevier, this journal boasts an impressive impact factor and is indexed with both ISSN 1367-0484 and E-ISSN 1476-5411. It stands out with a Q1 ranking in the categories of Medicine (miscellaneous), Ophthalmology, and Optometry, placing it at the forefront of scholarly research in its disciplines. With a comprehensive scope that encompasses the latest advancements in contact lens technology and anterior eye health, the journal serves as a crucial resource for researchers, healthcare professionals, and students aiming to enhance their knowledge and skills. The journal has been publishing cutting-edge research since its inception in 1997 and continues to pave the way in ophthalmic research through high-quality, peer-reviewed articles. Although it does not currently offer Open Access options, its availability through institutional subscriptions ensures that critical research reaches its intended audience effectively.

Translational Vision Science & Technology is a premier open access journal dedicated to the advancement of the field of ophthalmology and biomedical engineering. Published by the Association for Research in Vision and Ophthalmology, Inc., this journal has established itself as a leading source of high-quality research since its inception in 2013, achieving a remarkable impact factor reflective of its influential contribution to the field. With an impressive ranking of #21 in Ophthalmology and #120 in Biomedical Engineering within the Scopus database, it sits within the prestigious Q1 quartile for both categories as of 2023, further validating its significance. The journal's scope encompasses a wide variety of topics focused on the intersection of ophthalmological science and technological innovation, welcoming contributions that promote the understanding and treatment of visual disorders. Available as an Open Access publication since 2016, it ensures that cutting-edge research is freely accessible to researchers, practitioners, and students worldwide, facilitating the rapid dissemination of knowledge essential for the advancement of vision science.

Eye and Vision, published by BMC, is a leading open-access journal dedicated to the dynamic field of ophthalmology and visual sciences. With its ISSN 2326-0246 and E-ISSN 2326-0254, the journal has established itself as a premier platform for innovative research and clinical studies, achieving impressive rankings in 2023 as Q1 in both Health Professions (Miscellaneous) and Ophthalmology categories. The journal's commitment to accessible knowledge since its transition to open access in 2015 enhances its global reach, allowing researchers, clinicians, and students to share and access top-tier studies and advancements in the field. Located in the United Kingdom and delivering influential insights from 2014 through to 2024, Eye and Vision holds significant relevance, with a Scopus ranking placing it in the 99th percentile for Health Professions and the 93rd percentile for Ophthalmology, making it an essential resource for those looking to stay at the forefront of eye research and vision science.

Journal of the Egyptian Ophthalmological Society is a premier academic journal dedicated to advancing the field of ophthalmology through high-quality peer-reviewed research. Published by Wolters Kluwer Medknow Publications, this journal plays a critical role in disseminating vital findings and innovations in eye care, fostering knowledge exchange among researchers, practitioners, and educators worldwide. Since its transformation to Open Access in 2014, it has significantly enhanced the accessibility of eye health information, thereby broadening its impact on the global scientific community. With an ISSN of 2090-0686 and an E-ISSN of 2314-6648, the journal aims to tackle contemporary issues in ophthalmology, including clinical practices, public health, and technological advancements in eye care. The journal's commitment to excellence ensures that it remains a vital resource for those looking to contribute meaningfully to this dynamic and crucial field.

Strabismus is a distinguished journal published by Taylor & Francis Inc, dedicated to the field of ophthalmology, with a focus on the diagnosis, treatment, and research surrounding strabismic conditions. Since its inception in 1993, this journal has served as a pivotal platform for advancing knowledge and fostering discussion among researchers and clinicians alike, providing critical insights into the complexities of eye alignment disorders. With a current impact factor reflecting its solid standing in the Q3 quartile of ophthalmology journals, Strabismus continues to rank among the notable publications in its field, achieving a Scopus rank of #85 out of 137. Although it operates without an open access model, the journal is accessible to a broad audience of professionals through institutional subscriptions, ensuring that a wealth of research is available to support clinical practices. By encompassing a wide range of topics, from clinical studies to theoretical analyses, Strabismus aims to enhance understanding and improve patient outcomes, making it an essential resource for those engaged in ocular health and research.

Clinical Optometry is a prominent open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of ophthalmology and sensory systems. Established in 2010, this journal provides a platform for impactful research and insights that facilitate the understanding and treatment of visual disorders. With an impressive Scopus ranking of #58 in Ophthalmology and #28 in Neuroscience & Sensory Systems, Clinical Optometry is recognized for its contributions to the academic community, correlating with a Q3 classification in Ophthalmology and Q4 in Sensory Systems as of 2023. Based in New Zealand, this journal encourages researchers, professionals, and students to disseminate their findings, fostering a culture of knowledge sharing and collaboration in the field. For those interested in cutting-edge research, Clinical Optometry serves as an essential resource, offering a comprehensive collection of articles that enhance the understanding of ophthalmologic science.

PROGRESS IN RETINAL AND EYE RESEARCH, published by PERGAMON-ELSEVIER SCIENCE LTD, is a premier journal dedicated to the advancement of knowledge in the fields of ophthalmology and sensory systems. With an impressive impact factor and a Q1 category ranking in both Ophthalmology and Sensory Systems as of 2023, this journal exemplifies excellence in research dissemination. Given its stature, it ranks #1 out of 137 in Ophthalmology and #1 out of 42 in Neuroscience - Sensory Systems, placing it within the top percentile of scientific publications in these domains. The journal has been actively contributing to the field since its inception in 1994 and continues to be a vital resource for researchers, clinicians, and students seeking the latest insights and breakthroughs in the understanding of retinal diseases and eye health. While it maintains a traditional subscription model, the journal remains committed to publishing high-quality, peer-reviewed articles that drive forward the frontiers of eye research and therapeutic innovation. With its strong scientific rigor and a vast array of articles, PROGRESS IN RETINAL AND EYE RESEARCH is indispensable for anyone invested in the study of visual sciences.